JOHNSON & JOHNSON |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.9 EUR | -0.77% |
|
-1.53% | -5.84% |
| 03/07 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 03/07 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
